Press Releases
Clinerion becomes EHDEN certified, supporting the building of a federated health data network in Europe
Clinerion has been certified by EHDEN (European Health Data & Evidence Network) to map health data from various formats to the OMOP common data model.
As an OMOP ambassador, Clinerion will support the speeding up of the process to map...
Drug Research
Grey Wolf completes £2.5m Series A2 financing for development of therapies targeting ERAP2
Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology (IO), announces it has completed a £2.5 million ($3.3 million) Series A2 financing round with existing leading international healthcare investors Andera Partners and Canaan.
The...
Clinical Trials
Elsevier creates free information center to bring together latest clinical research on novel coronavirus 2019-nCoV
For the benefit of healthcare professionals, medical researchers and the public, Elsevier, a global information analytics business specializing in science and health, has created a Novel Coronavirus Information Center with free information in English and Mandarin on the novel...
IT & Data Management
Accenture and Google Cloud Collaborate to Help Life Sciences Companies Advance the Discovery, Development and Delivery of Innovative Therapies
Accenture and Google Cloud announced that Google Cloud will be the cloud technology provider for Accenture’s INTIENT life sciences industry platform.
The new, multi-year agreement brings Google’s cloud and artificial intelligence capabilities together with Accenture’s life sciences services and platforms...
Press Releases
RauCon Pharma Partnering Conferences Limit Attendance For More Value
RauCon has now introduced limits to the number of participants of its euroPLX and asiaPLX Pharma Partnering Conferences in order to increase their value for the individual participant.
The question whether or not expectations on a partnering event can be...
Clinical Trials
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has stepped up its efforts in enabling the development of multiple neutralizing antibodies for Novel Coronavirus (2019-nCoV) with its...
IT & Data Management
Clinerion and Datametrix partner to deliver RWE insights from Real World Data from Clinerion’s global hospital network
The partners will deliver an integrated clinical research offer transforming Real World Data (RWD) from the global site and patient network on Clinerion’s Patient Network Explorer into Real World Evidence (RWE) through the use of Datametrix’s analytical capabilities.
Together, Clinerion...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read